10
Total investments
3
Early stage
3
Mid stage
0
Late stage
8y
Years active
Portfolio
10 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2024
Hellometer makes managing fast food restaurants easier through computer vision technology. Our service analyzes workplace camera feeds to generate operations insights and recommendations. Think of it like a consultant that learns your business and is on site 24/7.
Investor
2024
🔋 At Bib, we are committed to accelerating the shift to sustainable electric mobility.
♻️ 🚗 Transportation makes up for 25% of European CO2 emissions. Transitioning to electric vehicles is essential—but progress remains too slow. High upfront costs, uncertainty about battery health, and barriers to a thriving second-hand market continue to hold it back.
Bibs mission is to:
1. Unlock battery transparency through data.
2. Extend battery lifespan through repair, second-life and recycling, in a compliant and cost-effective way.
📩 Contact us : https://bib-batteries.fr/contact !
Join us to make batteries greener ♻️
Investor
2024
Pump brings you the best group buying discounts and utilizes AI to arbitrage cloud expenses 24/7.
Get ~60% savings, zero engineering effort needed. #GetPumped #AWSBilling
Investor
2024
Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology.
At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women.
Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine.
Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability.
Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future.
🌐 www.ziwig.com
Investor
2024
JustAI is your AI-Marketer, a full-stack workflow that thinks, creates, optimizes, and measures in sync.
Built by growth leaders from Twitter & Pinterest to help lifecycle marketing finally scale.
Investor
2023
Industry-leading utility data collection.
Funded by Y-Combinator, General Catalyst, Singularity Capital.
Investor
2023
Array Labs builds advanced radar systems to help humanity understand and respond to changes across the physical world.
We’re launching a coordinated fleet of radar satellites to create a high-resolution 3D map of the Earth – updated in real time – enabling faster, smarter decision-making for government and commercial organizations supporting disaster response, infrastructure resilience, and mission-critical geopolitical intelligence.
We design and build our satellites end-to-end, producing the world’s most advanced earth observation satellites. Our fleet will deliver unprecedented levels of accuracy, coverage, and responsiveness to power critical insights precisely where they’re needed most.
Investor
2022
Stoquemarket is a marketplace to order everything you need for your restaurant.
Restaurant owners and suppliers save time and focus on their business.
Orders are simplified ! You find what you need quickly.
Experience · 12 entries
All (12)
Investments (10)
Founder (2)
2024
Investor
Jan 2024
Hellometer makes managing fast food restaurants easier through computer vision technology. Our service analyzes workplace camera feeds to generate operations insights and recommendations. Think of it like a consultant that learns your business and is on site 24/7.
Investor
2024
🔋 At Bib, we are committed to accelerating the shift to sustainable electric mobility.
♻️ 🚗 Transportation makes up for 25% of European CO2 emissions. Transitioning to electric vehicles is essential—but progress remains too slow. High upfront costs, uncertainty about battery health, and barriers to a thriving second-hand market continue to hold it back.
Bibs mission is to:
1. Unlock battery transparency through data.
2. Extend battery lifespan through repair, second-life and recycling, in a compliant and cost-effective way.
📩 Contact us : https://bib-batteries.fr/contact !
Join us to make batteries greener ♻️
Investor
2024
Pump brings you the best group buying discounts and utilizes AI to arbitrage cloud expenses 24/7.
Get ~60% savings, zero engineering effort needed. #GetPumped #AWSBilling
Investor
2024
Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology.
At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women.
Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine.
Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability.
Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future.
🌐 www.ziwig.com
Show all 12 entries ↓
Investment activity
2018–2024 · 10 investments
Recent (last 2 years)Earlier